Cyclin D1, p16 and retinoblastoma gene product expression as a predictor for prognosis in non-small cell lung cancer at stages I and II

Lung Cancer

Volumn 34, Issue 2, 2001, Pages 207-218

  Jin, Mulan ^a,c   Inoue, Shoichi ^a   Umemura, Tomohiro ^a   Moriya, Jun ^b   Arakawa, Mikio ^b   Nagashima, Kazuo ^c   Kato, Hiroyuki ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b HOKKAIDO UNIVERSITY HOSPITAL   (Japan)

^c HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cyclin D1; Non small cell lung cancer; p16; Prognosis; Retinoblastoma gene product

Indexed keywords

CYCLIN D1; GENE PRODUCT; PROTEIN P16;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER EPIDEMIOLOGY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; CYTOPATHOLOGY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; SURVIVAL TIME; TUMOR SUPPRESSOR GENE;

EID: 0034780882     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-5002(01)00225-2     Document Type: Article

References (39)

1. Performance and prognosis in patients with lung cancer
2. Results of surgical treatment of patients with T1N0M0 lung cancer
3. Prognostic values of stromal proportion and PCNA, Ki-67, and p53 proteins in patients with resected adenocarcinoma of the lung
4. Ki-67 immunostaining and other prognostic factors including tobacco smoking in patients with resected nonsmall cell lung carcinoma
5. Prognostic value of the quantified expression of p185 in non-small cell lung cancer
6. c-mos immunoreactivity is an indicator of good prognosis in lung cancer
7. Does immunointensity account for the differences in prognostic significance of Bcl-2 expression in non-small cell lung cancer?
8. Prognostic implications of calbindin-D29k expression in lung cancer: Analysis of 452 cases
9. Hypermethylation of the death-associated protein (DAP) kinase promoter and aggressiveness in stage I non-small-cell lung cancer
10. Prognostic significance of telomeric repeat length alterations in pathological stage I-IIIA non-small cell lung cancer
11. Prognostic significance of platelet and microvessel counts in operable non-small cell lung cancer
12. Overexpression of cyclin B1 in early-stage non-small cell lung cancer and its clinical implication
13. Cyclin D1 protein expression and gene polymorphism in colorectal cancer
14. MDM2 expression is associated with progress of disease and WAF1 expression in resected lung cancer
15. Immunohistochemical detection of mutant p53 protein in small-cell lung cancer: Relationship to treatment outcome
16. Prognostic significance of p53 alterations in patients with non-small cell lung cancer: A meta-analysis
17. Surgery for non-small cell lung cancer: Postoperative survival based on the revised tumor-node-metastasis classification and its time trend
18. Identification of prognostic factors determining risk group for lung resection
19. Prognostic implications of a positive bronchial resection margin
20. Bone-marrow microinvolvement in non-small cell lung cancer is not a reliable indicator of tumor recurrence and prognosis
21. Cyclins and their associated cyclin-dependent kinases in human cell cycle
22. Mammalian G1 cyclins
23. G1 phase progression cyclin on cue
24. Overexpression of cyclin D1 in rat fibroblasts causes abnormalities in growth control, cell cycle progression and gene expression
25. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4
26. A cell cycle regulator potentially involved in genesis of many tumor types
27. In vitro confirmation of newly established lung cancer cell lines using flow cytometry and multicellular tumor spheroids
28. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4
29. Reciprocal RB inactivation and p16INK4 expression in primary lung cancers and cell lines
30. Cellular localization and T antigen binding of the retinoblastoma protein
31. Intracellular compartments and protein sorting
32. Long-term survivors in metastatic non-small cell lung cancer
33. Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck
34. The expression of cyclins D1 and E in predicting short-term survival in squamous cell carcinoma of the lung
35. Expression of cyclin D1, Ki-67 and PCNA in non-small cell lung cancer: Prognostic significance and comparison with p53 and bcl-2
36. RB1 protein in normal and malignant human colorectal tissue and colon cancer cell lines
37. Point mutational inactivation of the retinoblastoma antioncogene
38. Relevance of proliferative and pro-apoptotic factors in non-small-cell lung cancer for patient survival
39. Cyclin D1 is a possible predictor of sensitivity to chemoradiotherapy for esophageal squamous cell carcinoma